[1] SOHNS C, MARROUCHE NF. Atrial fibrillation and cardiac fibrosis[J]. Eur Heart J, 2020, 41(10): 1123. doi: 10.1093/eurheartj/ehz786
[2] ZIMETBAUM P. Atrial Fibrillation[J]. Ann Intern Med, 2017, 166(5): ITC33. doi: 10.7326/AITC201703070
[3] ASPENSTRÖM P, FRANSSON A, SARAS J. Rho GTPases have diverse effects on the organization of the actin filament system[J]. Biochem J, 2004, 377(2): 327. doi: 10.1042/bj20031041
[4] SVENJA H, RIDLEY AJ, SUSANNE L. The function of Rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease[J]. Front Pharmacol, 2015, 6: 276. doi: 10.3389/fphar.2015.00276/pdf
[5] RAUT SK, KUMAR A, SINGH GB, et al. miR-30c mediates upregulation of Cdc42 and Pak1 in diabetic cardiomyopathy[J]. Cardiovasc Ther, 2015, 33(3): 89. doi: 10.1111/1755-5922.12113
[6] LI J, GAO E, VITE A, et al. Alpha-catenins control cardiomyocyte proliferation by regulating Yap activity[J]. Circ Res, 2015, 116(1): 70. doi: 10.1161/CIRCRESAHA.116.304472
[7] LIN ZQ, GUO HD, CAO Y, et al. Acetylation of VGLL4 regulates Hippo-YAP signaling and postnatal cardiac growth[J]. Dev Cell, 2016, 39(4): 466. doi: 10.1016/j.devcel.2016.09.005
[8] ROBERTS JD, GOLLOB MH. Impact of genetic discoveries on the classification of lone atrial fibrillation[J]. J Am CollCardiol, 2010, 55(8): 705. doi: 10.1016/j.jacc.2009.12.005
[9] LIP GY, TSE HF. Management of atrial fibrillation[J]. Lancet, 2007, 370(9587): 604. doi: 10.1016/S0140-6736(07)61300-2
[10] 单锋, 葛敏, 唐碧, 等. 二十二碳六烯酸对房颤大鼠心房纤维化的影响[J]. 蚌埠医学院学报, 2018, 43(4): 444.
[11] LIN Z, PU WT. Releasing YAP From an α-catenin trap increases cardiomyocyte proliferation[J]. Circ Res, 2015, 116(1): 9. doi: 10.1161/CIRCRESAHA.114.305496
[12] LIP GY, PATEL JV, HUGHES E, et al. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation relationship to stroke risk factors, stroke risk stratification schema, and prognosis[J]. Stroke, 2007, 38(4): 1229. doi: 10.1161/01.STR.0000260090.90508.3e
[13] WU N, CHEN X, CAI T, et al. Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: asystematic review and meta-analysis[J]. Can J Cardiol, 2015, 31(3): 278. doi: 10.1016/j.cjca.2014.12.002
[14] SPRONK HM, DE JONG AM, VERHEULE S, et al. Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation[J]. Eur Heart J, 2017, 38(1): 38. doi: 10.1093/eurheartj/ehw119
[15] STAERK L, SHERER JA, KO D, et al. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes[J]. Circ Res, 2017, 120(9): 1501. doi: 10.1161/CIRCRESAHA.117.309732
[16] MELENOVSKY V, HWANG SJ, REDFIELD MM, et al. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction[J]. Circ Heart Fail, 2015, 8(2): 295. doi: 10.1161/CIRCHEARTFAILURE.114.001667
[17] ZHU N, CHEN H, ZHAO X, et al. Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction[J]. Medicine(Baltimore), 2019, 98(48): e18146.
[18] LEE HL, HWANG YT, CHANG PC, et al. A three-year longitudinal study of the relation between left atrial diameter remodeling and atrial fibrillation ablation outcome[J]. J Geriatr Cardiol, 2018, 15(7): 486.
[19] AKKAYA M, HIGUCHI K, KOOPMANN M, et al. Higher degree of left atrial structural remodeling in patients with atrial fibrillation and left ventricular systolic dysfunction[J]. J Cardiovasc Electrophysiol, 2013, 24(5): 485. doi: 10.1111/jce.12090
[20] DEROANNE CF, HAMELRYCKX D, HO TT, et al. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway[J]. J Cell Sci, 2005, 118(Pt6): 1173.
[21] CHEN JL, LI QQ, DONG RP, et al. The effect of the Ras homolog gene family(Rho), member A/Rho associated coiled-coil forming protein kinase pathway in atrial fibrosis of type 2 diabetes in rats[J]. Exp Ther Med, 2014, 8(3): 836. doi: 10.3892/etm.2014.1843
[22] YANG Y, DEL RE PD, NAKANO N, et al. miR-206 mediates YAP-induced cardiac hypertrophy and survival[J]. Circ Res, 2015, 117(10): 891.
[23] LIN ZQ, ZHOU PZ, VON GISE A, et al. Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival[J]. Circ Res, 2015, 116(1): 35. doi: 10.1161/CIRCRESAHA.115.304457
[24] HU YF, CHEN YJ, LIN YJ, et al. Inflammation and the pathogenesis of atrial fibrillation[J]. Nat Rev Cardiol, 2015, 12(4): 230. doi: 10.1038/nrcardio.2015.2
[25] DVZEN IV, YAVUZ F, VURUSKAN E, et al. Investigation of leukocyte RHO/ROCK gene expressions in patients with non-valvular atrial fibrillation[J]. Exp Ther Med, 2019, 18(4): 2777.